Forever Young Pharmacy vs Paradigm Peptide
Independent side-by-side comparison across the 0 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Forever Young Pharmacy
503A compounding pharmacy. BPC-157 averages 7.2 across 5 tests. Most recent test from February 2025 — staleness flag.
Forever Young Pharmacy full review →Paradigm Peptide
Top Retatrutide vendor by score (9.0 across 14 tests). Strong on metabolic peptides.
Paradigm Peptide full review →Side-by-side breakdown
| PEPTIDE | FOREVER YOUNG PHARMACY | PARADIGM PEPTIDE | WINNER |
|---|---|---|---|
| BPC-157 |
6.2
C (5 tests)
|
—(not sold)
|
Forever Young Pharmacy only |
| Ipamorelin |
—(not sold)
|
9.0
A (6 tests)
|
Paradigm Peptide only |
| Tirzepatide |
—(not sold)
|
8.4
B+ (14 tests)
|
Paradigm Peptide only |
| Retatrutide |
—(not sold)
|
7.0
B (14 tests)
|
Paradigm Peptide only |
Which to choose
Across the 0 peptides both vendors sell, Forever Young Pharmacy scores higher on 0, Paradigm Peptide scores higher on 0, and 0 are within 0.3 points (effectively tied). Paradigm Peptide additionally sells Ipamorelin, Tirzepatide, Retatrutide; Forever Young Pharmacy does not. Forever Young Pharmacy additionally sells BPC-157; Paradigm Peptide does not.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Forever Young Pharmacy review · Paradigm Peptide review